Modeling hamsters for evaluating West Nile virus therapiesMONEY, John D; DAY, Craig W; JULANDER, Justin G et al.Antiviral research. 2004, Vol 63, Num 1, pp 41-50, issn 0166-3542, 10 p.Article

Efficacy of orally administered T-705 on lethal avian influenza a (HSN1) virus infections in miceSIDWELL, Robert W; BARNARD, Dale L; DAY, Craig W et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 3, pp 845-851, issn 0066-4804, 7 p.Article

Evaluation of immunomodulators, interferons and known in vitro SARS-CoV inhibitors for inhibition of SARS-CoV replication in BALB/c miceBARNARD, Dale L; DAY, Craig W; BAILEY, Kevin et al.Antiviral chemistry & chemotherapy. 2006, Vol 17, Num 5, pp 275-284, issn 0956-3202, 10 p.Article

Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5BN1 and H1N1 virus infections in miceBARNARD, Dale L; WONG, Min-Hui; BAILEY, Kevin et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 3, pp 125-132, issn 0956-3202, 8 p.Article

Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives : microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense virusesSELVAM, Periyasamy; VIJAYALAKSHIMI, Paulchamy; SMEE, Donald F et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 5, pp 301-305, issn 0956-3202, 5 p.Article

(-)-Carbodine: Enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu)RAO, Jagadeeshwar R; JHA, Ashok K; RAWAL, Ravindra K et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 8, pp 2601-2604, issn 0960-894X, 4 p.Article

Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelBARNARD, Dale L; DAY, Craig W; BAILEY, Kevin et al.Antiviral research. 2008, Vol 79, Num 2, pp 105-113, issn 0166-3542, 9 p.Article

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infectionsKUMAKI, Yohichi; DAY, Craig W; SMEE, Donald F et al.Antiviral research. 2011, Vol 92, Num 2, pp 329-340, issn 0166-3542, 12 p.Article

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinBARNARD, Dale L; DAY, Craig W; CARSON, Dennis A et al.Antiviral research. 2006, Vol 71, Num 1, pp 53-63, issn 0166-3542, 11 p.Article

Error-prone replication of West Nile virus caused by ribavirinDAY, Craig W; SMEE, Donald F; JULANDER, Justin G et al.Antiviral research. 2005, Vol 67, Num 1, pp 38-45, issn 0166-3542, 8 p.Article

Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building programTARBET, E. Bart; DORWARD, James T; DAY, Craig W et al.Vaccine. 2013, Vol 31, Num 12, pp 1646-1649, issn 0264-410X, 4 p.Article

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survivalJULANDER, Justin G; WINGER, Quinton A; OLSEN, Aaron L et al.Antiviral research. 2005, Vol 65, Num 2, pp 79-85, issn 0166-3542, 7 p.Article

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal modelsMORREY, John D; DAY, Craig W; JULANDER, Justin G et al.Antiviral chemistry & chemotherapy. 2004, Vol 15, Num 2, pp 101-109, issn 0956-3202, 9 p.Article